We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Curtis Pettaway

Curtis A Pettaway MD

Professor of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Dr. Pettaway is Professor of Urology at the University of Texas M.D. Anderson Cancer Center. One of his major areas of clinical research focus is in penile cancer where he has published on several themes including 1) Defining prognostic markers for inguinal lymph node metastasis and survival 2) Developing minimally invasive staging procedures that decrease the morbidity of standard lymphadenectomy and 3) Neoadjuvant chemotherapy followed by surgical resection for advanced penile cancer.